92-54-6 | 1-Phenylpiperazine

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$37.00	$26.00
25g	98%	in stock	$57.00	$40.00

Description

• Catalog Number: AB43438
• Chemical Name: 1-Phenylpiperazine
• CAS Number: 92-54-6
• Molecular Formula: C10H14N2
• Molecular Weight: 162.2316
• MDL Number: MFCD00005957
• SMILES: N1CCN(CC1)c1ccccc1

Computed Properties

• Complexity: 124
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 1.1

Literature

• Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action.

  Neurotoxicology 20151201

• Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats.

  Neuropharmacology 20121201

• DNA-binding, spectroscopic and antimicrobial studies of palladium(II) complexes containing 2,2'-bipyridine and 1-phenylpiperazine.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001

• Phenylpiperazine derivatives: a patent review (2006 - present).

  Expert opinion on therapeutic patents 20121001

• Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.

  ACS chemical neuroscience 20120919

• Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.

  Bioorganic & medicinal chemistry letters 20120715

• Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.

  Bioorganic & medicinal chemistry 20120401

• FT-IR and Raman spectroscopic and quantum chemical investigations of some metal halide complexes of 1-phenylpiperazine.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120301

• 3-(Adamantan-1-yl)-4-phenyl-1-[(4-phenyl-piperazin-1-yl)meth-yl]-1H-1,2,4-triazole-5(4H)-thione.

  Acta crystallographica. Section E, Structure reports online 20120201

• [Design, synthesis and characterization of cyanopyrrolidine-bearing compounds as DPP-4 inhibitors].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120201

• Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.

  Bioorganic & medicinal chemistry 20120115

• Bivalent molecular probes for dopamine D2-like receptors.

  Bioorganic & medicinal chemistry 20120101

• Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.

  Clinical therapeutics 20120101

• How full is our antihypertensives pipeline?

  Journal of pharmacology & pharmacotherapeutics 20120101

• Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.

  PloS one 20120101

• Synthesis and vibrational spectroscopic analysis of some Hofmann type clathrates.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111101

• Ligand discovery from a dopamine D3 receptor homology model and crystal structure.

  Nature chemical biology 20111101

• 10α-Hy-droxy-4,9-dimethyl-13-[(4-phenyl-piperazin-1-yl)meth-yl]-3,8,15-trioxatetra-cyclo-[10.3.0.0.0]tetra-decan-14-one.

  Acta crystallographica. Section E, Structure reports online 20111101

• Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.

  Bioorganic & medicinal chemistry letters 20111001

• Molecular dynamics study of small molecule inhibitors of the Bcl-2 family.

  Proteins 20110901

• Biophysical mapping of the adenosine A2A receptor.

  Journal of medicinal chemistry 20110714

• Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum.

  Neuroreport 20110713

• Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.

  Journal of medicinal chemistry 20110609

• N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.

  Journal of medicinal chemistry 20110526

• The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.

  Journal of medicinal chemistry 20110414

• Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor.

  Molecular pharmacology 20110301

• The clinical toxicology of the designer 'party pills' benzylpiperazine and trifluoromethylphenylpiperazine.

  Clinical toxicology (Philadelphia, Pa.) 20110301

• The effects of the 4-(4-Methylpiperazine)phenyl group on nucleosides and oligonucleotides: cellular delivery, detection, and stability.

  Chemistry, an Asian journal 20110201

• Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats.

  Neuropharmacology 20110101

• Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice.

  Pharmacological reports : PR 20110101

• A novel structural framework for α(1A/D)-adrenoceptor selective antagonists identified using subtype selective pharmacophores.

  PloS one 20110101

• Structure-cardiovascular activity relationships in a group of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-aminopropyl)-3,7-dihydro-1H-purine-2,6-diones.

  Pharmacological reports : PR 20110101

• Oxidation of fluoroquinolone antibiotics and structurally related amines by chlorine dioxide: Reaction kinetics, product and pathway evaluation.

  Water research 20101201

• Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.

  Bioorganic & medicinal chemistry letters 20101015

• Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry.

  Journal of chromatography. A 20101001

• 1-Phenyl-piperazine-1,4-diium bis-(hydrogen sulfate).

  Acta crystallographica. Section E, Structure reports online 20101001

• Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.

  Bioorganic & medicinal chemistry 20100915

• 4-Phenyl-piperazin-1-ium dihydrogen phosphate.

  Acta crystallographica. Section E, Structure reports online 20100901

• [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.

  Synapse (New York, N.Y.) 20100601

• Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581.

  Bioorganic & medicinal chemistry letters 20100501

• Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).

  Journal of medicinal chemistry 20100325

• Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways.

  Synapse (New York, N.Y.) 20100301

• Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.

  Bioorganic & medicinal chemistry 20100301

• Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: a new step towards the design of high-affinity 5-HT1A ligands.

  Bioorganic & medicinal chemistry letters 20100201

• Animal violence demystified.

  Frontiers in behavioral neuroscience 20100101

• Metabotropic glutamate receptors: potential drug targets for psychiatric disorders.

  The open medicinal chemistry journal 20100101

• [(18)F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20091101

• Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.

  European journal of pharmacology 20090915

• [(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.

  Synapse (New York, N.Y.) 20090901

• Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.

  Journal of medicinal chemistry 20090813

• Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.

  Bioorganic & medicinal chemistry 20090701

• Acaricidal properties of piperazine and its derivatives against house-dust and stored-food mites.

  Pest management science 20090601

• 1-Chloro-2-(4-phenyl-piperazin-1-yl)ethanone.

  Acta crystallographica. Section E, Structure reports online 20090601

• Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.

  Journal of medicinal chemistry 20090528

• Application of a library of artificial receptors formed by the self-organization of N-lipidated peptides immobilized on cellulose in studying the effects of the incorporation of a fluorine atom.

  Journal of combinatorial chemistry 20090101

• Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

  Neuropharmacology 20090101

• Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.

  Acta poloniae pharmaceutica 20090101

• SONU20176289, a compound combining partial dopamine D(2) receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression.

  European journal of pharmacology 20081119

• Probe compounds to quantify cation exchange and complexation interactions of ciprofloxacin with soils.

  Environmental science & technology 20081115

• Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.

  Bioorganic & medicinal chemistry 20080901

• NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds.

  Bioorganic & medicinal chemistry 20080901

• FT-IR spectroscopic investigation of some Hofmann type complexes: M(1-phenylpiperazine)2Ni(CN)4 (M=Ni, Co, Cd, Pd or Mn).

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080701

• 1-(4-Chloro-phen-yl)piperazine-1,4-diium tetra-chlorido-zincate(II) monohydrate.

  Acta crystallographica. Section E, Structure reports online 20080701

• Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.

  Bioorganic & medicinal chemistry 20080601

• Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype.

  The Journal of pharmacy and pharmacology 20080601

• (Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.

  Journal of medicinal chemistry 20080424

• Determination of lipophilicity of alpha-(4-phenylpiperazine) derivatives of N-benzylamides using chromatographic and computational methods.

  Biomedical chromatography : BMC 20080401

• Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.

  Pharmacology, biochemistry, and behavior 20080301

• Trazodone for Alzheimer's disease: a naturalistic follow-up study.

  Archives of gerontology and geriatrics 20080101

• Two new phenylpiperazines with atypical antipsychotic potential.

  Bioorganic & medicinal chemistry letters 20071101

• From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor.

  Journal of medicinal chemistry 20070726

• FT-IR and NMR investigation of 1-phenylpiperazine: a combined experimental and theoretical study.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070701

• Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.

  Chemical biology & drug design 20070401

• Identification of metabolites produced from N-phenylpiperazine by Mycobacterium spp.

  Journal of industrial microbiology & biotechnology 20070301

• Adsorption and oxidation of fluoroquinolone antibacterial agents and structurally related amines with goethite.

  Chemosphere 20070101

• Patented small molecule inhibitors in the ubiquitin proteasome system.

  BMC biochemistry 20070101

• Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.

  Bioorganic & medicinal chemistry 20061115

• Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors.

  Journal of medicinal chemistry 20060824

• BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline.

  Bioorganic & medicinal chemistry letters 20060401

• Binding and photocleavage of cationic porphyrin-phenylpiperazine hybrids to DNA.

  Biophysical chemistry 20060201

• In vitro metabolism studies of (18)F-labeled 1-phenylpiperazine using mouse liver S9 fraction.

  Nuclear medicine and biology 20060201

• Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.

  European journal of drug metabolism and pharmacokinetics 20060101

• Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.

  Bioorganic & medicinal chemistry letters 20051101

• Synthesis of potent and selective serotonin 5-HT1B receptor ligands.

  Bioorganic & medicinal chemistry letters 20051101

• Complete assignments of 1H and 13C NMR data for ten phenylpiperazine derivatives.

  Magnetic resonance in chemistry : MRC 20051001

• Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20051001

• [A study of physicochemical properties of 2-, 3-, 4-alkoxyphenylcarbamic acid derivatives with a substituted N-phenylpiperazine moiety in the basic part].

  Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20050901

• Oxidative transformation of fluoroquinolone antibacterial agents and structurally related amines by manganese oxide.

  Environmental science & technology 20050615

• Electrospray ionization mass and tandem mass spectra of a series of N-pyrazolylmethyl and N-triazolylmethyl N-phenylpiperazines: new dopaminergic ligands with potential antipsychotic properties.

  Journal of mass spectrometry : JMS 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.

  Journal of medicinal chemistry 20050407

• Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.

  Drug and alcohol dependence 20050214

• Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.

  Bioorganic & medicinal chemistry 20050103

• Interaction of arylpiperazines with the dopamine receptor D2 binding site.

  Arzneimittel-Forschung 20050101

• Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.

  Pharmacological reports : PR 20050101

• Synthesis and biological evaluation of new thiazolyl/benzothiazolyl-amides, derivatives of 4-phenyl-piperazine.

  Farmaco (Societa chimica italiana : 1989) 20050101

• Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.

  Clinical practice and epidemiology in mental health : CP & EMH 20050101

• Fluorous reagents and scavengers versus solid-supported reagents and scavengers, a reaction rate and kinetic comparison.

  Molecular diversity 20050101

• Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.

  European journal of medicinal chemistry 20041201

• Acute psychosis following ingestion of 'Rapture'.

  Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20041201

• Synthesis of novel N-alkyl carbamates of a-substituted amides of g-hydroxybutyric acid as potential acetylcholinesterase inhibitors.

  Acta poloniae pharmaceutica 20041201

• Electrophoretic behavior and pKa determination of quinolones with a piperazinyl substituent by capillary zone electrophoresis.

  Journal of chromatography. A 20041008

• Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazines.

  Archiv der Pharmazie 20040901

• New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of 'THIQ'.

  Journal of medicinal chemistry 20040826

• Synthesis and radioiodination of selective ligands for the dopamine D3 receptor subtype.

  Bioorganic & medicinal chemistry letters 20040802

• Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry.

  Therapeutic drug monitoring 20040801

• Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.

  Archiv der Pharmazie 20040701

• 1- and 2-substituted naphthalenes: a new class of potential hypotensive agents.

  Bioorganic & medicinal chemistry letters 20040607

• Discovery of a potent and selective alpha v beta 3 integrin antagonist with strong inhibitory activity against neointima formation in rat balloon injury model.

  Bioorganic & medicinal chemistry letters 20040517

• Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning.

  Journal of medicinal chemistry 20040422

• Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.

  Journal of medicinal chemistry 20040408

• Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor.

  European journal of medicinal chemistry 20040401

• Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis.

  Therapeutic drug monitoring 20040401

• Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion.

  Bioorganic & medicinal chemistry 20040315

• Ruthenium-catalyzed anti-Markovnikov hydroamination of vinylarenes.

  Journal of the American Chemical Society 20040310

• Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20040301

• Discovery of transdermal penetration enhancers by high-throughput screening.

  Nature biotechnology 20040201

• Validated HPLC method for determination of LASSBio-581, a new heterocyclic N-phenylpiperazine derivative, in rat plasma.

  Journal of pharmaceutical and biomedical analysis 20031204

• Intermolecular, markovnikov hydroamination of vinylarenes with alkylamines.

  Journal of the American Chemical Society 20031126

• Aryl piperazine melanocortin MC4 receptor agonists.

  Bioorganic & medicinal chemistry letters 20031103

• Synthesis of totarol amino alcohol derivatives and their antiplasmodial activity and cytotoxicity.

  Bioorganic & medicinal chemistry 20031001

• New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.

  Journal of medicinal chemistry 20030703

• Rhodium-catalyzed anti-Markovnikov hydroamination of vinylarenes.

  Journal of the American Chemical Society 20030514

• Dopaminergic profile of new heterocyclic N-phenylpiperazine derivatives.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20030501

• Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.

  Journal of medicinal chemistry 20030410

• A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030301

• Effects of nefazodone on voluntary ethanol consumption induced by isolation stress in young and aged rats.

  Pharmacology, biochemistry, and behavior 20021001

• Alpha(1)-adrenoceptor antagonists. 4. Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives.

  Journal of medicinal chemistry 20020815

• Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.

  Pharmacology, biochemistry, and behavior 20020401

• Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. II. Optimization of the phenylpiperazine moiety of 1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenes.

  Chemical & pharmaceutical bulletin 20020401

• Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.

  European journal of medicinal chemistry 20020301

• Central nervous system activity of new pyrimidine-8-on[2,1-f]theophylline-9-alkylcarboxylic acids derivatives.

  Polish journal of pharmacology 20020101

• Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.

  Die Pharmazie 20011001

• Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists.

  Journal of enzyme inhibition 20011001

• 1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2).

  Bioorganic & medicinal chemistry letters 20010723

• Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists.

  Bioorganic & medicinal chemistry 20010501

• Cytotoxic activity of 2-aminomethylene-3(2H)-benzofuranones against human oral tumor cell lines.

  Anticancer research 20010101

• Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.

  Polish journal of pharmacology 20010101

• Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.

  Polish journal of pharmacology 20010101